If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
TREATMENT STRATEGIES
HEPATOLOGY
Volume 2 Issue 1
• Congress Review
• Hepatic Encephalopathy
• Liver Disease
• Liver Failure
• Liver Transplantaion
• Metabolism
Includes a Review of the 50th Annual
Meeting of the EASL - ILC 2015
Robust protection against
recurrent episodes of hepatic
encephalopathy (HE)1
2-YEAR
DATA
6-month data
Daily treatment with XIFAXAN® 550* b.d. plus lactulose significantly reduced episodes† and
hospitalisations‡ compared with placebo plus lactulose1, and improved quality of life2 in
patients with HE.
2-year data
The reduction in hospitalisations compared to placebo plus lactulose observed over 6 months
is maintained over 2 years in patients treated with XIFAXAN® 550 b.d. plus lactulose.1,3 The
2-year infection rates are lower than those observed in patients treated with XIFAXAN® 550
TREATMENT STRATEGIES HEPATOLOGY Volume 2 Issue 1
Robust protection against recurrent episodes of h
TREATMENT HEPATOLOGY STRATEGIES - TREATMENT ST
CHRONIC LIVER DISEASEA SLOW, SILENT, BUT PREVENTA
CONTENTS... 03 08 11 13 14 15 16 16
GLOBAL STAFFING SOLUTIONS Cont
35 43 49 55 5
TREATMENT STRATEGIES - HEPATOLOGY Editorial Advis
MONDAY 02 JUNE 2014 NORGINE ADVERT
For the latest hepatitis treatment news and infor
Treatment Strategies - Congress Review The Inte
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review Vienna, Au
Treatment Strategies - Congress Review Talkin
Treatment Strategies - Congress Review 50th An
Treatment Strategies - Congress Review All-oral,
Treatment Strategies - Congress Review NAFLD Pati
Treatment Strategies - Congress Review Hepatitis
Treatment Strategies - Congress Review New Study
Treatment Strategies - Congress Review Delaying H
Treatment Strategies - Congress Review Late-Brea
Treatment Strategies - Congress Review Transgene
Treatment Strategies - Congress Review AbbVie Pre
Treatment Strategies - Congress Review Treatment
Treatment Strategies - Congress Review Treatment
Treatment Strategies - Congress Review Sofosbuvir
Treatment Strategies - Congress Review make meani
Treatment Strategies - Congress Review New Rea
Treatment Strategies - Congress Review Once-da
Treatment Strategies - Congress Review Non-alcoho
Treatment Strategies - Congress Review
Treatment Strategies - Congress Review The Intern
Treatment Strategies - Congress Review safe and m
Treatment Strategies - Congress Review The Inter
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
(‘NACSELD-II’) is to identify the determinants of
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Hepatic Encephalopathy
Treatment Strategies - Liver Disease System
Treatment Strategies - Liver Disease intermedi
Treatment Strategies - Liver Disease
Treatment Strategies - Liver Disease in contro
References 1. Williams R, Aspinall R, Bellis M et
The International Liver Cancer Association Announ
Treatment Strategies - Liver Failure Defini
Treatment Strategies - Liver Failure of the di
patients with ALF from a patient with ALF or CLF.
Treatment Strategies - Liver Failure
References 1. Kuntz E, Kuntz HD (eds.), Hepatolog
European School of Oncology e-ESO se
Treatment Strategies - Liver Transplantation
Treatment Strategies - Liver Transplantation o
in the blood (CDT), urine (urinary ethylglucuroni
Treatment Strategies - Liver Transplantation Re
Treatment Strategies - Metabolism Hepatic-b
Treatment Strategies - Metabolism patient with
Alpha-1 Antitrypsin Deficiency A1ATD is an autoso
Treatment Strategies - Metabolism One patient
References 1. Garrod AE. The incidence of alkapto
Treatment Strategies - Metabolism 2013;5:238-5
Treatment Strategies - Events Listing Upc
Treatment Strategies - Events Listing 22nd Inte
Robust protection against recurrent episodes of h
The Cambridge Research Centre The Cambridge